Rwanda, 250,000 more people receive AstraZeneca vaccine: no adverse events recorded
Covid vaccine: in Rwanda, in the heart of Africa, Covid vaccinations using AstraZeneca are continuing. The European controversy has increased vigilance, but no cases of patients with adverse reactions to the vaccine have been recorded.
An additional 250,000 people have been registered with the AstraZeneca vaccine and zero health problems have been observed.
Covid vaccine: Rwanda has been vaccinating nationwide for a fortnight
Minister of Health Daniel Ngamije said the country will continue to roll out the vaccine until there is scientific evidence to suggest it is not safe.
His comments come at a time when several European countries have suspended the use of AstraZeneca after some people developed blood clot complications.
The World Health Organization (WHO) and AstraZeneca have said there is no evidence linking the vaccine to the blood clots.
“The link between blood clot cases and the vaccine is still a research question. It might be a coincidence. What’s confirmed so far is that WHO approved the vaccine and Rwanda Food and Drug Authority approved it too,” Dr Ngamije said, adding that the vaccine might have mild short-term side effects, especially after the second dose.
Read Also:
Africa, Lack Of Vaccines: ‘Risk Of Increasing Covid Variants’.
China Approves Fifth Covid Vaccine, But Little Data On Latest Trials